What are the approved strengths of desloratadine compared to bilastine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Desloratadine vs Bilastine: Approved Strengths

Desloratadine is approved at 5 mg once daily, while bilastine is approved at 20 mg once daily for adults and adolescents 12 years and older. 1

FDA-Approved Dosing

Desloratadine

  • Standard strength: 5 mg tablet, taken once daily 1
  • May be taken without regard to meals 1
  • For patients with hepatic or renal impairment: 5 mg every other day 1

Bilastine

  • Standard strength: 20 mg once daily 2
  • This is the approved dose in 28 European countries for allergic rhinoconjunctivitis and urticaria in adults and children over 12 years 3, 4

Clinical Context: Comparative Efficacy at Standard Doses

While the question asks about strength (dosing), understanding comparative efficacy at these approved doses is clinically relevant:

At their respective standard doses (bilastine 20 mg vs desloratadine 5 mg), bilastine demonstrates superior antihistaminic activity. In head-to-head comparison, bilastine 20 mg showed significantly greater inhibition of histamine-induced wheal and flare responses compared to desloratadine 5 mg throughout a 24-hour period (83% vs 38% maximum wheal inhibition at 6 hours, p < 0.001) 5. However, for overall symptom control in seasonal allergic rhinitis, both medications showed comparable clinical efficacy 2.

Important Dosing Considerations

  • Desloratadine can be up-dosed: In non-responsive chronic spontaneous urticaria patients, desloratadine can be increased to 10 mg daily (double the standard dose) with demonstrated safety and efficacy 6, 7
  • Bilastine can be up-dosed: Guidelines support up-dosing bilastine to four times the conventional dose (80 mg daily) in refractory cases with excellent safety profile 7
  • Both medications are non-sedating at recommended doses 8

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.